EN
HI
Aarti Pharmalabs share price chart
Aarti Pharmalabs Share Key Metrics
Volume
5.20 L
Market Cap
7814.24 CR
LTQ@LTP
3@861.95
ATP
866.89
Var Margin
50 %
Circuit Range
681-1021.4
Delivery %
38.93 %
Value
45.12 CR
ASM/GSM
No
Market Lot
1
Summary
AARTIPHARM stock price is ₹861.95 as of 18 Aug, 2026. The stock intraday movement has stayed between ₹851.35 and ₹885.00, while Aarti Pharmalabs share price 52 week high low is ₹585.00 & ₹946.10.
In terms of trading activity, AARTIPHARM share price has recorded a volume of 5,20,496 shares. The Aarti Pharmalabs has a market cap of ₹90657751. The stock’s Average Traded Price (ATP) stands at ₹866.89, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 3 @ ₹861.95.
The Aarti Pharmalabs upper circuit limit is ₹1021.40 & The Aarti Pharmalabs lower circuit limit is ₹681.00, with a Value of ₹45.12 CR. The Delivery Percentage for the day is 38.93%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Aarti Pharmalabs Fundamentals
P/E Ratio
36.25
P/B Ratio
3.52
Div. Yield
0.41
Sector P/E
63.94
Sector P/B
3.3
Sec. Div. Yield
0.51
Aarti Pharmalabs Resistance and Support
Pivot 859.33
Resistance
First Resistance
873.36
Second Resistance
895.53
Third Resistance
909.56
Support
First Support
837.16
Second Support
823.13
Third Support
800.96
Aarti Pharmalabs Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Aug 17 2026 | 860 | 861.95 | 1.26% | 885 | 851.35 |
| Fri Aug 14 2026 | 873 | 851.2 | -2.57% | 881.5 | 845.29 |
| Thu Aug 13 2026 | 894.9 | 873.65 | -1.69% | 898.95 | 865.09 |
Aarti Pharmalabs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-07 | Quarterly Results |
| 2026-05-25 | Audited Results & Final Dividend |
| 2026-05-18 | Audited Results & Final Dividend |
| 2026-02-09 | Quarterly Results & Interim Dividend |
| 2025-11-09 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-10 | Audited Results & Final Dividend |
| 2025-02-05 | Quarterly Results |
| 2024-10-28 | Quarterly Results |
| 2024-08-05 | Quarterly Results |
Aarti Pharmalabs News
Aarti Pharmalabs Ltd - 543748 - Record Date For Dividend For FY 2025-26
Aarti Pharma Labs set September 15, 2026, as the record date for a ₹2.00 final dividend for FY26. The dividend, representing 40% of face value, will be paid by October 20, 2026, subject to AGM approval.
Aug 17 2026 17:24:19
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Aarti Pharma Labs has uploaded the audio recording of its Investors/Analyst Earnings Conference Call for the first quarter ended June 30, 2026, on its website. This allows investors to access management commentary on the unaudited financial results.
Aug 10 2026 21:39:03
Read More
Aarti Pharmalabs Management
| Name | Position |
|---|---|
| Jeevan Mondkar | Company Secretary |
| Chandrakant V Gogri | Chairman Emeritus |
Aarti Pharmalabs Similar Stocks
Thyrocare Technologies Ltd.
618.60
-5.45 (0.87%)
Suven Life Sciences Ltd.
333.05
-9.30 (2.72%)
Strides Pharma Science Ltd.
987.10
19.30 (1.99%)
Procter & Gamble Health Ltd.
5836.50
-95.50 (1.61%)
Yatharth Hospital & Trauma Care Services Ltd.
842.85
-1.85 (0.22%)
Sanofi India Ltd.
3197.40
-45.50 (1.40%)
Nephrocare Health Services Ltd.
694.65
-2.05 (0.29%)
Senores Pharmaceuticals Ltd.
1545.70
68.00 (4.60%)
Kovai Medical Center & Hospital Ltd.
6122.00
83.50 (1.38%)
Orchid Pharma Ltd.
998.35
-47.30 (4.52%)
Aarti Pharmalabs FAQs
The Buying Price of Aarti Pharmalabs share is 861.95 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aarti Pharmalabs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aarti Pharmalabs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aarti Pharmalabs shares is 36.25. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aarti Pharmalabs shares is 3.52. Useful to assess the stock's value relative to its book value.
To assess Aarti Pharmalabs’s valuation compare Sector P/E, P/B which are 63.94 & 3.3 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aarti Pharmalabs is 7814.24 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aarti Pharmalabs share price is 946.10 & 585.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aarti Pharmalabs belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in AARTIPHARM
Or Download Choice FinX App
Invest in AARTIPHARM
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade